[144] Pentair plc SEC Filing

Rhea-AI Filing Summary

Pentair plc (PNR) – Form 144 filing

An unidentified insider has notified the SEC of an intent to sell up to 158,315 common shares through Fidelity Brokerage Services on the NYSE around 24 Jul 2025. Based on the filing’s reference price, the planned sale is valued at approximately $16.26 million and equals about 0.10 % of Pentair’s 163.9 million shares outstanding.

The shares were obtained chiefly via option exercises granted between 2018-2024 and multiple restricted-stock vesting events; no sales have occurred in the previous three months. While the notice does not obligate the insider to complete the transaction, it establishes a 90-day window to execute the trade under Rule 144. Such filings can create a modest supply overhang, yet the volume is minor relative to Pentair’s average daily trading and should not materially affect the company’s fundamentals.

Positive

• None.

Negative

• Insider intends to sell 158,315 shares (~$16.3 M), potentially adding short-term supply pressure

Insights

Securities Analyst

TL;DR: 158k-share Form 144 (~$16 M) is only 0.1 % of float; insignificantly dilutive but may add short-term supply pressure.

The filing signals a potential insider liquidity event, not an equity issuance, so no direct dilution occurs. The block is roughly one day of PNR’s average volume, suggesting minimal market impact if executed over time. Absence of recent insider sales and the methodological acquisition via compensation plans limit negative interpretation. Still, investors often watch Form 144 activity as an early indicator of insider sentiment; continued filings could hint at a less constructive internal outlook.

Corporate Governance Expert

TL;DR: Routine Rule 144 notice; transaction size small, governance risk low, transparency maintained.

The seller certifies no undisclosed adverse information, fulfilling Rule 144 and 10b5-1 safeguards. Because the sales stem from compensation plans, the move aligns with typical diversification behavior rather than strategic divestment. Lack of bundling with other insiders reduces concerns over coordinated selling. I consider the governance impact immaterial, though stakeholders should monitor for additional filings that could signal shifting executive confidence.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	158315	16258492.64	163931255	07/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/24/2025	Options Granted 01/03/2022	Issuer			11964	07/24/2025	Cash
Common	07/24/2025	Options Granted 01/03/2023	Issuer			12444	07/24/2025	Cash
Common	07/24/2025	Options Granted 05/02/2018	Issuer			15457	07/24/2025	Cash
Common	07/24/2025	Options Granted 01/02/2019	Issuer			21154	07/24/2025	Cash
Common	07/24/2025	Options Granted 01/02/2020	Issuer			18217	07/24/2025	Cash
Common	07/24/2025	Options Granted 01/04/2021	Issuer			18053	07/24/2025	Cash
Common	07/24/2025	Options Granted 01/02/2024	Issuer			3616	07/24/2025	Cash
Common	01/02/2021	Restricted Stock Vesting	Issuer			1763	01/02/2021	Compensation
Common	02/15/2021	Restricted Stock Vesting	Issuer			5902	02/15/2021	Compensation
Common	05/02/2021	Restricted Stock Vesting	Issuer			629	05/02/2021	Compensation
Common	12/04/2021	Restricted Stock Vesting	Issuer			11025	12/04/2021	Compensation
Common	01/02/2022	Restricted Stock Vesting	Issuer			1806	01/02/2022	Compensation
Common	01/04/2022	Restricted Stock Vesting	Issuer			968	01/04/2022	Compensation
Common	02/21/2022	Restricted Stock Vesting	Issuer			7921	02/21/2022	Compensation
Common	02/20/2023	Restricted Stock Vesting	Issuer			9587	02/20/2023	Compensation
Common	01/03/2024	Restricted Stock Vesting	Issuer			1640	01/03/2024	Compensation
Common	01/04/2024	Restricted Stock Vesting	Issuer			1001	01/04/2024	Compensation
Common	02/19/2024	Restricted Stock Vesting	Issuer			8619	02/19/2024	Compensation
Common	01/02/2025	Restricted Stock Vesting	Issuer			678	01/02/2025	Compensation
Common	01/03/2025	Restricted Stock Vesting	Issuer			1766	01/03/2025	Compensation
Common	02/24/2025	Restricted Stock Vesting	Issuer			4105	02/24/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Pentair (PNR) shares are covered by this Form 144?

The filing covers 158,315 common shares.

What is the estimated value of the shares to be sold?

The aggregate market value stated is approximately $16.26 million.

What percentage of Pentair’s outstanding shares does this represent?

Roughly 0.10 % of the 163.9 million shares outstanding.

When can the sale occur under Rule 144?

The filer indicates an approximate sale date of 24 Jul 2025; Rule 144 allows execution within 90 days of filing.

Were there any Pentair insider sales in the past three months?

The filer reported no sales during the preceding three-month period.

How were the shares originally acquired?

They were obtained via stock-option exercises and restricted-stock vesting between 2018 and 2024.